Fataladverseevents相关论文
Risk of fatal adverse events associated with bevacizumab,cetuximab,and panitumumab in 25,000 patient
Objective The present meta-analysis was conducted to evaluate the fatal adverse events(FAEs)of targeted drugs including ......
Background: Ipilimumab is a fully human immunoglobulin G1 monoclonal antibody that increases antitumor T-cell respon......
